Baldwin Brothers LLC Organon & Co. Transaction History

Baldwin Brothers LLC

$1.27 Billion
Q2 2024

A detailed history of Baldwin Brothers LLC transactions in Organon & Co. stock. As of the latest transaction made, Baldwin Brothers LLC holds 475 shares of OGN stock, worth $9,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares

475

Previous 475 -0.0%

Holding current value

$9,110

Previous $8,000 12.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$13.78 - $18.8 $1,515 - $2,068	-110 Reduced 18.8%	475 $8,000
Q4 2023 Jan 08, 2024	SELL	$10.95 - $17.32 $5,573 - $8,815	-509 Reduced 46.53%	585 $8,000
Q3 2023 Oct 10, 2023	SELL	$16.59 - $23.77 $1,708 - $2,448	-103 Reduced 8.6%	1,094 $18,000
Q2 2023 Jul 14, 2023	SELL	$19.27 - $24.63 $3,487 - $4,458	-181 Reduced 13.13%	1,197 $24,000
Q1 2023 Apr 21, 2023	SELL	$21.42 - $32.08 $4,412 - $6,608	-206 Reduced 13.01%	1,378 $32,000
Q4 2022 Jan 27, 2023	BUY	$23.31 - $28.61 $2,027 - $2,489	87 Added 5.81%	1,584 $0
Q3 2022 Oct 14, 2022	SELL	$23.4 - $34.25 $5,077 - $7,432	-217 Reduced 12.66%	1,497 $35,000
Q2 2022 Jul 18, 2022	BUY	$31.66 - $38.9 $54,265 - $66,674	1,714 New	1,714 $58,000
Q1 2022 Apr 13, 2022	SELL	$30.45 - $39.36 $189,916 - $245,488	-6,237 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$28.67 - $37.13 $168,464 - $218,175	-5,876 Reduced 48.51%	6,237 $190,000
Q3 2021 Oct 27, 2021	SELL	$28.63 - $35.64 $176,303 - $219,471	-6,158 Reduced 33.7%	12,113 $397,000
Q2 2021 Jul 30, 2021	BUY	$28.45 - $38.0 $519,809 - $694,298	18,271 New	18,271 $553,000

Others Institutions Holding OGN

# of Institutions

795

Shares Held

191M

Call Options Held

1.59M

Put Options Held

931K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Organon & Co. Transaction History